Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity

Fig. 3

Survival curves for all patients according to international prognostic index (IPI). The patients were treated with PEG-L-CHOP every 21 days for 6 cycles. Survival analyses were performed according to IPI score using Kaplan-Meier method. Patients with IPI score of 2 or higher had poor efficacy than patients with IPI score 0~ 1. p = 0.0186 by log-rank test

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us